Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment on Smoking Cessation Intervention in ADHD Smokers: A Randomized, Double-Blind, Placebo-Controlled TrialWINHUSEN, Theresa M; SOMOZA, Eugene C; LEWIS, Daniel F et al.The Journal of clinical psychiatry. 2010, Vol 71, Num 12, pp 1680-1688, issn 0160-6689, 9 p.Article

Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failureFELKER, G. Michael; GATTIS, Wendy A; LEIMBERGER, Jeffrey D et al.The American journal of cardiology. 2003, Vol 92, Num 5, pp 625-628, issn 0002-9149, 4 p.Article

Randomized Controlled Trial of Osmotic- Release Methylphenidate With Cognitive- Behavioral Therapy in Adolescents With Aitention-Deficit/Hyperactivity Disorder and Substance Use DisordersRIGGS, Paula D; WINHUSEN, Theresa; JAFFEE, William B et al.Journal of the American Academy of Child and Adolescent Psychiatry. 2011, Vol 50, Num 9, pp 903-914, issn 0890-8567, 12 p.Article

Usefulness of Beta Blockers in High-Risk Patients After Myocardial Infarction in Conjunction With Captopril and/or Valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] Trial)CALIFF, Robert M; LOKHNYGINA, Yuliya; VELAZQUEZ, Eric J et al.The American journal of cardiology. 2009, Vol 104, Num 2, pp 151-157, issn 0002-9149, 7 p.Article

Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure : Results from the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (OPTIME-CHF) studyKLEIN, Liviu; O'CONNOR, Christopher M; LEIMBERGER, Jeffrey D et al.Circulation (New York, N.Y.). 2005, Vol 111, Num 19, pp 2454-2460, issn 0009-7322, 7 p.Article

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarctionANAVEKAR, Nagesh S; MCMURRAY, John J. V; ZELENKOFSKE, Steven et al.The New England journal of medicine. 2004, Vol 351, Num 13, pp 1285-1295, issn 0028-4793, 11 p.Article

Clinical Outcomes in patients on beta-blocker therapy admitted with worsening chronic hear failureGATTIS, Wendy A; O'CONNOR, Christopher M; LEIMBERGER, Jeffrey D et al.The American journal of cardiology. 2003, Vol 91, Num 2, pp 169-174, issn 0002-9149, 6 p.Article

Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of Acute myocardial infarction: The valsartan in Acute myocardial infarction (VALIANT) trialAGUILAR, David; SOLOMON, Scott D; BELENKOV, Yuri N et al.Circulation (New York, N.Y.). 2004, Vol 110, Num 12, pp 1572-1578, issn 0009-7322, 7 p.Article

Heart Failure Etiology and response to Milrinone in decompensated heart failure: Results from the OPTIME-CHF studyFELKER, G. Michael; BENZA, Raymond L; CHANDLER, A. Bleakley et al.Journal of the American College of Cardiology. 2003, Vol 41, Num 6, pp 997-1003, issn 0735-1097, 7 p.Article

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or bothPFEFFER, Marc A; MCMURRAY, John J. V; LEIMBERGER, Jeffrey D et al.The New England journal of medicine. 2003, Vol 349, Num 20, pp 1893-1906, issn 0028-4793, 14 p.Article